Valuation: Alfresa Holdings Corporation

Market Cap 400B 2.48B 2.17B 2B 1.85B 3.5B 236B 3.56B 23.88B 9.38B 116B 9.3B 9.1B P/E 2027 *
16.9x
P/E 2028 * 13.6x
Enterprise Value 400B 2.48B 2.17B 2B 1.85B 3.5B 236B 3.56B 23.88B 9.38B 116B 9.3B 9.1B EV / Sales 2027 *
0.13x
EV / Sales 2028 * 0.12x
Free-Float
88.28%
Yield 2027 *
3.23%
Yield 2028 * 3.59%
22/06 Alfresa Holdings Corporation(TSE:2784) dropped from S&P Japan Mid Cap 100 CI
27/05 ReeNT Co., Ltd. announced that it expects to receive ¥600 million in funding from Alfresa Holdings Corporation CI
27/05 Alfresa Holdings Corporation concluded a share transfer agreement to acquire Nagashima Medical Instruments Co., Ltd. from Nagashima Holdings Co., Ltd. CI
18/05 Alfresa Holdings Corporation's Equity Buyback announced on May 15, 2026, has closed with 6,307,800 shares, representing 3.47% for ¥14,999.95 million. CI
18/05 Tranche Update on Alfresa Holdings Corporation's Equity Buyback Plan announced on May 15, 2026. CI
15/05 Alfresa Holdings Corporation authorizes a Buyback Plan. CI
15/05 Alfresa Holdings Corporation announces an Equity Buyback for 6,307,800 shares, representing 3.46% for ¥14,999.95 million. CI
15/05 Alfresa Holdings Corp - to buy back up to 3.5% of own shares worth about 15 billion yen RE
15/05 Alfresa Holdings Corporation Announces Cash Dividend for the Year-End of the Fiscal Year Ended March 31, 2026, Payable on June 2, 2026; Provides Cash Dividend Guidance for the Second Quarter-End and Year-End of the Fiscal Year Ending March 31, 2027 CI
15/05 Alfresa Holdings Corporation Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2026 and for the Fiscal Year Ending March 31, 2027 CI
07/04 Healios Secures 144 Million Yen Initial Order from Alfresa's Korean Unit for Cosmetic Raw Material MT
27/02 Alfresa Holdings Corporation concluded a share transfer agreement to acquire Techno Suzuta, Co.,Ltd. from Onsendo, K.K. CI
10/02 Alfresa Books 15.4 Billion Yen Gain from Sale Of Investment Securities MT
1 day-1.10%
1 week+1.57%
Current month+1.26%
1 month-0.38%
3 months-13.75%
6 months-12.74%
Current year-9.44%
1 week 2,182
Extreme 2182
2,246.5
1 month 2,144.5
Extreme 2144.5
2,246.5
Current year 2,106.5
Extreme 2106.5
2,685.5
1 year 2,017
Extreme 2017
2,685.5
3 years 1,897
Extreme 1897
2,685.5
5 years 1,505
Extreme 1505
2,685.5
10 years 1,505
Extreme 1505
3,350
Manager TitleAgeSince
Chief Executive Officer 63 -
Chief Tech/Sci/R&D Officer 63 28/06/2022
Corporate Officer/Principal 61 01/04/2020
Director TitleAgeSince
Director/Board Member 50 01/06/2020
Director/Board Member 63 01/06/2007
Director/Board Member 72 01/06/2020
Change 5-day change 1-year change 3-year change Capi.($)
-1.10%+1.57%+9.97%+3.16% 2.49B
-0.25%-2.05%-29.89%-12.48% 164B
+2.08%-0.06%-7.15%-3.98% 105B
+0.23%+1.43%+1.85%+57.03% 58.85B
+0.79%-2.40%+44.99%+53.08% 51.05B
+1.10%-2.25%-14.34%-40.97% 41.57B
+0.40%-4.21% - - 34.54B
+2.17%+2.61%-13.09%-43.14% 28.18B
-0.89%-1.02%+54.42%-6.18% 25.27B
-1.73%-1.15%-11.75%+1.32% 20.24B
Average +0.23%-0.52%+3.89%+0.87% 53.21B
Weighted average by Cap. +0.48%-0.70%-6.16%+1.12%

Financials

2027 *2028 *
Net sales 3,164B 19.59B 17.14B 15.81B 14.6B 27.7B 1,869B 28.17B 189B 74.17B 920B 73.56B 71.96B 3,253B 20.14B 17.61B 16.25B 15.01B 28.47B 1,921B 28.95B 194B 76.23B 946B 75.61B 73.97B
Net income 25.25B 156M 137M 126M 116M 221M 14.91B 225M 1.51B 592M 7.34B 587M 574M 28.12B 174M 152M 140M 130M 246M 16.6B 250M 1.68B 659M 8.18B 654M 639M
Net Debt - -
Logo Alfresa Holdings Corporation
Alfresa Holdings Corporation is a Japan-based holding company primarily engaged in the wholesale of drugs. The Company operates in four business segments. The Pharmaceutical Wholesale segment is engaged in the wholesale of medical products, test reagents, as well as medical equipment and materials. The Self Medication Wholesale segment is engaged in the wholesale of general drugs. The Pharmaceutical Manufacture segment is engaged in the manufacture and sale of pharmaceuticals, test reagents, medical equipment and implements, as well as pharmaceutical powders. The Medical-Related segment is mainly engaged in operation of pharmacies. The others business is engaged in the information system business, the transportation business, the warehousing business, the insurance agency business, the real estate management business, the sale of miscellaneous goods, as well as the manpower dispatching business, among others.
Employees
12,525
Date Price Change Volume
10/07/26 JPY 2,201.50 -1.10% 715,900
09/07/26 JPY 2,226.00 -0.20% 426,800
08/07/26 JPY 2,230.50 +0.93% 510,200
07/07/26 JPY 2,210.00 +0.18% 348,900
06/07/26 JPY 2,206.00 +1.29% 330,900
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
2,201.50JPY
Average target price
2,500.00JPY
Spread / Average Target
+13.56%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2784 Stock